Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Ischemic Heart Disease

Free Subscription Articles published in Atherosclerosis Retrieve available abstracts of 159 articles: HTML format Text format

Single Articles

May 2018
1. BALCER B, Dykun I, Schlosser T, Forsting M, et al
   Pericoronary fat volume but not attenuation differentiates culprit lesions in patients with myocardial infarction.
   Atherosclerosis. 2018 May 25. pii: S0021-9150(18)30278.
   PubMed     Text format     Abstract available
   
   
   
2. VENEGAS-PINO DE, Lagrotteria A, Wang PW, Morphet J, et al
   Evidence of extensive atherosclerosis, coronary artery disease and myocardial infarction in the ApoE(-/-):Ins2(+/Akita) mouse fed a western diet.
   Atherosclerosis. 2018;275:88-96.
   PubMed     Text format     Abstract available
   
   
   
3. MACHADO GP, Araujo GN, Carpes CK, Lech M, et al
   Comparison of neutrophil-to-lymphocyte ratio and mean platelet volume in the prediction of adverse events after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
   Atherosclerosis. 2018;274:212-217.
   PubMed     Text format     Abstract available
   
   
   
4. DONG SY, Yan ST, Wang ML, Li ZB, et al
   Associations of body weight and weight change with cardiovascular events and mortality in patients with coronary heart disease.
   Atherosclerosis. 2018;274:104-111.
   PubMed     Text format     Abstract available
   
   
   
5. SHEN ZX, Yang QZ, Li C, Du LJ, et al
   Myeloid peroxisome proliferator-activated receptor gamma deficiency aggravates myocardial infarction in mice.
   Atherosclerosis. 2018;274:199-205.
   PubMed     Text format     Abstract available
   
   
   
6. HUMPHRIES SE, Cooper JA, Seed M, Capps N, et al
   Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register.
   Atherosclerosis. 2018;274:41-46.
   PubMed     Text format     Abstract available
   
   
   April 2018
7. WILCOX T, Newman JD, Maldonado TS, Rockman C, et al
   Peripheral vascular disease risk in diabetic individuals without coronary heart disease.
   Atherosclerosis. 2018 Apr 30. pii: S0021-9150(18)30211.
   PubMed     Text format     Abstract available
   
   
   
8. LAVIN B, Protti A, Lorrio S, Dong X, et al
   MRI with gadofosveset: A potential marker for permeability in myocardial infarction.
   Atherosclerosis. 2018 Apr 25. pii: S0021-9150(18)30209.
   PubMed     Text format     Abstract available
   
   
   March 2018
9. DHAR I, Lysne V, Seifert R, Svingen GFT, et al
   Plasma methionine and risk of acute myocardial infarction: Effect modification by established risk factors.
   Atherosclerosis. 2018;272:175-181.
   PubMed     Text format     Abstract available
   
   
   
10. WILLIAMS BA, Chagin KM, Bash LD, Boden WE, et al
    External validation of the TIMI risk score for secondary cardiovascular events among patients with recent myocardial infarction.
    Atherosclerosis. 2018;272:80-86.
    PubMed     Text format     Abstract available
    
    
    
11. CARLSSON AC, Jansson JH, Soderberg S, Ruge T, et al
    Levels of soluble tumor necrosis factor receptor 1 and 2, gender, and risk of myocardial infarction in Northern Sweden.
    Atherosclerosis. 2018;272:41-46.
    PubMed     Text format     Abstract available
    
    
    February 2018
12. YIN H, Pickering JG
    Aortic smooth muscle cells and myocardial infarction: Does the ascending aorta feel a heart attack?
    Atherosclerosis. 2018 Feb 10. pii: S0021-9150(18)30080.
    PubMed     Text format    
    
    
    January 2018
13. MARACLE CX, Agca R, Helder B, Meeuwsen JAL, et al
    Noncanonical NF-kappaB signaling in microvessels of atherosclerotic lesions is associated with inflammation, atheromatous plaque morphology and myocardial infarction.
    Atherosclerosis. 2018;270:33-41.
    PubMed     Text format     Abstract available
    
    
    
14. WONGSURAWAT T, Woo CC, Giannakakis A, Lin XY, et al
    Distinctive molecular signature and activated signaling pathways in aortic smooth muscle cells of patients with myocardial infarction.
    Atherosclerosis. 2018 Jan 29. pii: S0021-9150(18)30024.
    PubMed     Text format     Abstract available
    
    
    December 2017
15. HAMAZAKI K, Iso H, Eshak ES, Ikehara S, et al
    Plasma levels of n-3 fatty acids and risk of coronary heart disease among Japanese: The Japan Public Health Center-based (JPHC) study.
    Atherosclerosis. 2017 Dec 8. pii: S0021-9150(17)31423.
    PubMed     Text format     Abstract available
    
    
    
16. NISHIHIRA K, Shibata Y, Yamashita A, Kuriyama N, et al
    Relationship between thrombus age in aspirated coronary material and mid-term major adverse cardiac and cerebrovascular events in patients with acute myocardial infarction.
    Atherosclerosis. 2017;268:138-144.
    PubMed     Text format     Abstract available
    
    
    October 2017
17. ERCAN E
    Statin treatment in dialysis patients after acute myocardial infarction improves overall mortality.
    Atherosclerosis. 2017 Oct 23. pii: S0021-9150(17)31348.
    PubMed     Text format     Abstract available
    
    
    September 2017
18. CHUNG CM, Lin MS, Chang CH, Cheng HW, et al
    Moderate to high intensity statin in dialysis patients after acute myocardial infarction: A national cohort study in Asia.
    Atherosclerosis. 2017 Sep 27. pii: S0021-9150(17)31288.
    PubMed     Text format     Abstract available
    
    
    
19. POKHAREL Y, Sharma PP, Qintar M, Lu Y, et al
    High-sensitivity C-reactive protein levels and health status outcomes after myocardial infarction.
    Atherosclerosis. 2017;266:16-23.
    PubMed     Text format     Abstract available
    
    
    
20. SAITO I, Yamagishi K, Kokubo Y, Yatsuya H, et al
    Association of high-density lipoprotein cholesterol concentration with different types of stroke and coronary heart disease: The Japan Public Health Center-based prospective (JPHC) study.
    Atherosclerosis. 2017;265:147-154.
    PubMed     Text format     Abstract available
    
    
    August 2017
21. GITT AK, Lautsch D, Ferrieres J, De Ferrari GM, et al
    Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II.
    Atherosclerosis. 2017;266:158-166.
    PubMed     Text format     Abstract available
    
    
    
22. ATTARD R, Dingli P, Doggen CJM, Cassar K, et al
    The independent effect of helicobacter pylori infection and elevated gastrin levels on the risk of myocardial infarction.
    Atherosclerosis. 2017;263:e96-e97.
    PubMed     Text format    
    
    
    
23. WOO CC, Wongsurawat T, Soong R, Lee CN, et al
    Distinctive pattern of LET-7B and MIR-30B in human aortic smooth muscle cells of myocardial infarction patients.
    Atherosclerosis. 2017;263:e63.
    PubMed     Text format    
    
    
    
24. KIM TH, Kang K, Kim EM, Park HE, et al
    Mesenchymal stem cells promote the infiltration of myeloid derived suppressor cells in a mouse myocardial infarction model.
    Atherosclerosis. 2017;263:e60.
    PubMed     Text format    
    
    
    
25. KURDI A, De Meyer GRY, Martinet W
    Everolimus attenuates atherosclerotic plaque progression, intraplaque neovascularization, myocardial infarction and sudden death in a mouse model of advanced atherosclerosis.
    Atherosclerosis. 2017;263:e59.
    PubMed     Text format    
    
    
    
26. DOULAMIS I, Tzani A, Konstantopoulos P, Gkogkos A, et al
    Sirtuin-1 and MMP-2 levels in patients with advanced coronary artery disease: A combined index for incidence of myocardial infarction.
    Atherosclerosis. 2017;263:e53.
    PubMed     Text format    
    
    
    
27. RYAZANKINA N, Manchurov V, Vasilieva E, Shpektor A, et al
    Improved in-hospital clinical outcomes in patients with acute ST-elevation myocardial infarction undergoing remote ischemic preconditioning before primary percutaneous coronary intervention.
    Atherosclerosis. 2017;263:e49-e50.
    PubMed     Text format    
    
    
    
28. MARINKOVIC G, Winkler L, Kefene L, Nilsson J, et al
    The alarmin complex S100A8/9 as a potential therapeutic target after myocardial infarction.
    Atherosclerosis. 2017;263:e48-e49.
    PubMed     Text format    
    
    
    
29. PFETSCH V, Sanin V, Jaensch A, Dallmeier D, et al
    Increased concentrations of soluble ST2 independently predict cardiac and total mortality but not non-fatal cardiovascular events in stable coronary heart disease patients.
    Atherosclerosis. 2017;263:e46-e47.
    PubMed     Text format    
    
    
    
30. ANTIOCHOS P, Marques-Vidal P, Virzi J, Pagano S, et al
    Impact of CD14 polymorphisms on anti-apolipoprotein A-1 IGG-related coronary heart disease prediction in the general population.
    Atherosclerosis. 2017;263:e45.
    PubMed     Text format    
    
    
    
31. PECHERINA T, Kashtalap V, Barbarash O
    Effects of statins on inflammatory markers and matrix metalloproteinases in patients with ST-segment elevation myocardial infarction.
    Atherosclerosis. 2017;263:e45-e46.
    PubMed     Text format    
    
    
    
32. BOUZID K, Ben Ahmed H, Boussaid H, Kamoun M, et al
    Relationship between galectin-3 levels in ST elevation myocardial infarction and the burden of atherosclerosis.
    Atherosclerosis. 2017;263:e275.
    PubMed     Text format    
    
    
    
33. NIZOMOV A, Kenjaev S
    Effect of high-dose atorvastatin on lipid spectrum and inflammation in acute myocardial infarction.
    Atherosclerosis. 2017;263:e245-e246.
    PubMed     Text format    
    
    
    
34. AZIZ N, Sirojiddin K, Majid K
    Influence of high doses of atorvastatin on myocardial stanning in acute myocardial infarction.
    Atherosclerosis. 2017;263:e245.
    PubMed     Text format    
    
    
    
35. GRAESDAL A, Dybvig A
    Lipoprotein apheresis as a treatment modality for familial combined hyperlipidemia (FCH) with non-alcoholic fatty liver disease (NAFLD) and coronary heart disease: a casuistic approach.
    Atherosclerosis. 2017;263:e243-e244.
    PubMed     Text format    
    
    
    
36. BATURINA O, Mironova O
    Clinical case of hyperlipidemia type IV in a man with diabetes, myocardial infarction and stroke.
    Atherosclerosis. 2017;263:e227-e228.
    PubMed     Text format    
    
    
    
37. REVNIC CR, Revnic F, Pena C, Nica AS, et al
    Biochemical studies of atherogenic potential of serum from patients with unstable angina coronary atherosclerosis.
    Atherosclerosis. 2017;263:e219-e220.
    PubMed     Text format    
    
    
    
38. QAYYUM F, Lauridsen B, Frikke-Schmidt R, Nordestgaard B, et al
    Genetic variants in CYP7A1 and risk of myocardial infarction and symptomatic gallstone disease.
    Atherosclerosis. 2017;263:e21.
    PubMed     Text format    
    
    
    
39. PAPADOPOULOS D, Grassos H, Sanidas E, Barbetseas J, et al
    Triglyceride blood levels and metalloproteinases activity in acute myocardial infarction patients.
    Atherosclerosis. 2017;263:e203.
    PubMed     Text format    
    
    
    
40. FEDOROVA N, Kashtalap V, Barbarash O
    Galectin-3 levels in patients with ST segment elevation myocardial infarction.
    Atherosclerosis. 2017;263:e199.
    PubMed     Text format    
    
    
    
41. PECHERINA T, Kashtalap V, Barbarash O, Zhuravleva E, et al
    The value of matrix metalloproteinases in coronary atherosclerosis progression in patients after ST-segment elevation myocardial infarction in one year.
    Atherosclerosis. 2017;263:e198.
    PubMed     Text format    
    
    
    
42. ZIVOTIC I, Zivkovic M, Djuric T, Stankovic A, et al
    Rs10757278 from 9p21 is associated with ST-elevated myocardial infarction in females in population of Serbia.
    Atherosclerosis. 2017;263:e188.
    PubMed     Text format    
    
    
    
43. FARES AL, Hussein El Bacha AA, Souza CS, Garcia De Carvalho JA, et al
    High prevalence of familial hypercholesterolemia in patients with coronary heart disease at a Brazilian quaternary healthcare center.
    Atherosclerosis. 2017;263:e181-e183.
    PubMed     Text format    
    
    
    
44. DJORDJEVIC A, Zivkovic M, Dekleva M, Markovic-Nikolic N, et al
    SNPS in the vicinity of LGALS-3 locus and different shape-types of heart remodeling after the first myocardial infarction: Preliminary results.
    Atherosclerosis. 2017;263:e180.
    PubMed     Text format    
    
    
    
45. NUSSBAUMEROVA B, Rosolova H, Mayer O Jr, Filipovsky J, et al
    Residual cardiovascular risk in patients with stable coronary heart disease over the last 16 years (Czech part of the EUROASPIRE I-IV surveys).
    Atherosclerosis. 2017;263:e177.
    PubMed     Text format    
    
    
    
46. KASHTALAP V, Barbarash O, Gorbunova E, Sedyh D, et al
    Psychophysiological personality characteristics of patients with recurrent myocardial infarction.
    Atherosclerosis. 2017;263:e174.
    PubMed     Text format    
    
    
    
47. IGNATEVA O, Berkovich O, Volkova E, Moroshkina N, et al
    S19W polymorphism of apo AV is an independent risk factor for myocardial infarction among young men.
    Atherosclerosis. 2017;263:e173-e174.
    PubMed     Text format    
    
    
    
48. DIAZ-PEROMINGO JA, Macia-Rodriguez C, Alende-Castro V, Paez-Guillan E, et al
    Comorbidity and sex differences among patients with ischemic heart disease currently smokers.
    Atherosclerosis. 2017;263:e172.
    PubMed     Text format    
    
    
    
49. KECHIDA M, Jomaa W, Hamda KB, Klii R, et al
    Myocardial infarction as a first symptom of activated protein C resistance associated to hyperhomocyteinemia.
    Atherosclerosis. 2017;263:e162.
    PubMed     Text format    
    
    
    
50. NIZOMOV A, Kenjaev M, Kenjaev S, Kenjaev S, et al
    The relationship between the parameters of longitudinal systolic function and left ventricular remodeling in patients with acute myocardial infarction.
    Atherosclerosis. 2017;263:e159.
    PubMed     Text format    
    
    
    
51. HONG TJ, Lee HW, Choi JH, Choi JC, et al
    Comparison of long term clinical outcomes between bare metal stent versus different types of drug eluting stents for treatment of acute myocardial infarction.
    Atherosclerosis. 2017;263:e155-e156.
    PubMed     Text format    
    
    
    
52. SHALAEVA A, Dadabaeva N
    Compliance initiatives in management of patients with coronary artery disease after acute myocardial infarction.
    Atherosclerosis. 2017;263:e152-e153.
    PubMed     Text format    
    
    
    
53. SHAH N, Meira L, Elliott R, Bordin D, et al
    DNA repair measuring DNA ligase activity in non ST-elevation myocardial infarction determines atherosclerotic plaque instability.
    Atherosclerosis. 2017;263:e143.
    PubMed     Text format    
    
    
    
54. SHAH N, Meira L, Forrer-Charlier C, Mahmoudi M, et al
    Up-regulation of base excision repair gene 8-oxoguanine glycosylase 1 expression in non ST-elevation myocardial infarction and correlation with atherosclerotic fibrous cap thickness.
    Atherosclerosis. 2017;263:e142-e143.
    PubMed     Text format    
    
    
    
55. ROMANOVA V
    Condition of adhesive endothelial function in coronary heart disease patients.
    Atherosclerosis. 2017;263:e141.
    PubMed     Text format    
    
    
    
56. DUMITRIU IE, Bulenkamp J, Chhetri I
    Homeostatic cytokines interleukin-7 (IL-7) and IL-15 drive the expansion and activation of CD4+CD28null t cells in patients with myocardial infarction.
    Atherosclerosis. 2017;263:e14-e15.
    PubMed     Text format    
    
    
    
57. NIZOMOV A, Kenjaev S, Kenjaev M, Mukhamedova M, et al
    Dynamics of indicators of longitudinal left ventricular systolic function in patients with acute myocardial infarction during stress echocardiography with dobutamine.
    Atherosclerosis. 2017;263:e122.
    PubMed     Text format    
    
    
    
58. MUSIKHINA N, Petelina T, Gapon L, Emeneva I, et al
    Peculiarity of vascular inflammatory response in patients with unstable angina.
    Atherosclerosis. 2017;263:e118.
    PubMed     Text format    
    
    
    
59. VERWEIJ S, Delewi R, Stiekema L, Versloot M, et al
    Prolonged inflammatory state after myocardial infarction.
    Atherosclerosis. 2017;263:e117-e118.
    PubMed     Text format    
    
    
    
60. KUMAR V
    Demonstrating the decline in coronary heart disease mortality in the Central Delhi, India between 2010 to 2015.
    Atherosclerosis. 2017;263:e110.
    PubMed     Text format    
    
    
    
61. DE GONZALO CALVO D, Sanchez Vega J, Vilades D, Nasarre L, et al
    Diagnostic value of circulating miRNAs: Association with the presence and extension of coronary atherosclerosis in patients with suspected ischemic heart disease.
    Atherosclerosis. 2017;263:e106.
    PubMed     Text format    
    
    
    July 2017
62. AGARWALA A, Pokharel Y, Saeed A, Sun W, et al
    The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study.
    Atherosclerosis. 2017;262:131-137.
    PubMed     Text format     Abstract available
    
    
    
63. HOLMLUND A, Lampa E, Lind L
    Oral health and cardiovascular disease risk in a cohort of periodontitis patients.
    Atherosclerosis. 2017;262:101-106.
    PubMed     Text format     Abstract available
    
    
    
64. CHUNG RWS, Leanderson P, Lundberg AK, Jonasson L, et al
    Lutein exerts anti-inflammatory effects in patients with coronary artery disease.
    Atherosclerosis. 2017;262:87-93.
    PubMed     Text format     Abstract available
    
    
    
65. TOUTOUZAS K, Benetos G, Koutagiar I, Barampoutis N, et al
    Noninvasive detection of increased carotid artery temperature in patients with coronary artery disease predicts major cardiovascular events at one year: Results from a prospective multicenter study.
    Atherosclerosis. 2017;262:25-30.
    PubMed     Text format     Abstract available
    
    
    
66. ZHANG Q, Wang A, Zhang S, Li N, et al
    Asymptomatic polyvascular disease and the risks of cardiovascular events and all-cause death.
    Atherosclerosis. 2017;262:1-7.
    PubMed     Text format     Abstract available
    
    
    
67. CHO I, O Hartaigh B, Gransar H, Valenti V, et al
    Prognostic implications of coronary artery calcium in the absence of coronary artery luminal narrowing.
    Atherosclerosis. 2017;262:185-190.
    PubMed     Text format     Abstract available
    
    
    June 2017
68. MOXON JV, Jones RE, Wong G, Weir JM, et al
    Baseline serum phosphatidylcholine plasmalogen concentrations are inversely associated with incident myocardial infarction in patients with mixed peripheral artery disease presentations.
    Atherosclerosis. 2017;263:301-308.
    PubMed     Text format     Abstract available
    
    
    
69. VONGPROMEK R, Bos S, Ten Kate GR, Bujo H, et al
    Soluble LR11 associates with aortic root calcification in asymptomatic treated male patients with familial hypercholesterolemia.
    Atherosclerosis. 2017 Jun 9. pii: S0021-9150(17)30268.
    PubMed     Text format     Abstract available
    
    
    
70. HUANG F, Liu Y, Yang X, Che D, et al
    Shexiang Baoxin pills promotes angiogenesis in myocardial infarction rats via up-regulation of 20-HETE-mediated endothelial progenitor cells mobilization.
    Atherosclerosis. 2017;263:184-191.
    PubMed     Text format     Abstract available
    
    
    
71. FAIROOZY RH, Cooper J, White J, Giambartolomei C, et al
    Identifying low density lipoprotein cholesterol associated variants in the Annexin A2 (ANXA2) gene.
    Atherosclerosis. 2017;261:60-68.
    PubMed     Text format     Abstract available
    
    
    
72. WANG A, Kwee LC, Grass E, Neely ML, et al
    Whole blood sequencing reveals circulating microRNA associations with high-risk traits in non-ST-segment elevation acute coronary syndrome.
    Atherosclerosis. 2017;261:19-25.
    PubMed     Text format     Abstract available
    
    
    
73. NAKAJIMA S, Ito H, Mitsuhashi T, Kubo Y, et al
    Clinical application of effective atomic number for classifying non-calcified coronary plaques by dual-energy computed tomography.
    Atherosclerosis. 2017;261:138-143.
    PubMed     Text format     Abstract available
    
    
    
74. TADA H, Kawashiri MA, Sakata K, Yoneda T, et al
    Renal glucosuria is not associated with atherosclerotic cardiovascular disease outcome in a general Japanese community.
    Atherosclerosis. 2017;261:111-116.
    PubMed     Text format     Abstract available
    
    
    May 2017
75. ERIKSSON OSTMAN M, Calais F, Rosenblad A, Frobert O, et al
    Prognostic impact of subclinical or manifest extracoronary artery diseases after acute myocardial infarction.
    Atherosclerosis. 2017;263:53-59.
    PubMed     Text format     Abstract available
    
    
    
76. FERNANDEZ-SANLES A, Sayols-Baixeras S, Subirana I, Degano IR, et al
    Association between DNA methylation and coronary heart disease or other atherosclerotic events: A systematic review.
    Atherosclerosis. 2017 May 18. pii: S0021-9150(17)30225.
    PubMed     Text format     Abstract available
    
    
    
77. SHARIFI M, Higginson E, Bos S, Gallivan A, et al
    Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia.
    Atherosclerosis. 2017 May 13. pii: S0021-9150(17)30218.
    PubMed     Text format     Abstract available
    
    
    
78. HARRIS WS, Del Gobbo L, Tintle NL
    The Omega-3 Index and relative risk for coronary heart disease mortality: Estimation from 10 cohort studies.
    Atherosclerosis. 2017;262:51-54.
    PubMed     Text format     Abstract available
    
    
    
79. NOLLET E, Hoymans VY, Rodrigus IR, De Bock D, et al
    Accelerated cellular senescence as underlying mechanism for functionally impaired bone marrow-derived progenitor cells in ischemic heart disease.
    Atherosclerosis. 2017;260:138-146.
    PubMed     Text format     Abstract available
    
    
    
80. GLEISSNER CA, Erbel C, Linden F, Domschke G, et al
    Galectin-3 binding protein, coronary artery disease and cardiovascular mortality: Insights from the LURIC study.
    Atherosclerosis. 2017;260:121-129.
    PubMed     Text format     Abstract available
    
    
    
81. VERDOIA M, Nardin M, Rolla R, Marino P, et al
    Immature platelet fraction and the extent of coronary artery disease: A single centre study.
    Atherosclerosis. 2017;260:110-115.
    PubMed     Text format     Abstract available
    
    
    
82. PANH L, Ruidavets JB, Rousseau H, Petermann A, et al
    Association between serum alkaline phosphatase and coronary artery calcification in a sample of primary cardiovascular prevention patients.
    Atherosclerosis. 2017;260:81-86.
    PubMed     Text format     Abstract available
    
    
    
83. BASKARAN L, O Hartaigh B, Schulman-Marcus J, Gransar H, et al
    Dense calcium and lesion-specific ischemia: A comparison of CCTA with fractional flow reserve.
    Atherosclerosis. 2017;260:163-168.
    PubMed     Text format     Abstract available
    
    
    April 2017
84. MANGILI LC, Miname MH, Silva PRS, Bittencourt MS, et al
    Achilles tendon xanthomas are associated with the presence and burden of subclinical coronary atherosclerosis in heterozygous familial hypercholesterolemia: A pilot study.
    Atherosclerosis. 2017 Apr 30. pii: S0021-9150(17)30189.
    PubMed     Text format     Abstract available
    
    
    
85. ALBREKTSEN G, Heuch I, Lochen ML, Thelle DS, et al
    Risk of incident myocardial infarction by gender: Interactions with serum lipids, blood pressure and smoking. The Tromso Study 1979-2012.
    Atherosclerosis. 2017;261:52-59.
    PubMed     Text format     Abstract available
    
    
    
86. KITAHARA H, Waseda K, Sakamoto K, Yamada R, et al
    Impact of attenuated-signal plaque observed by intravascular ultrasound on vessel response after drug-eluting stent implantation.
    Atherosclerosis. 2017;259:68-74.
    PubMed     Text format     Abstract available
    
    
    March 2017
87. LI S, Wu NQ, Zhu CG, Zhang Y, et al
    Significance of lipoprotein(a) levels in familial hypercholesterolemia and coronary artery disease.
    Atherosclerosis. 2017;260:67-74.
    PubMed     Text format     Abstract available
    
    
    
88. MATSUNAGA M, Yatsuya H, Iso H, Yamashita K, et al
    Similarities and differences between coronary heart disease and stroke in the associations with cardiovascular risk factors: The Japan Collaborative Cohort Study.
    Atherosclerosis. 2017 Mar 6. pii: S0021-9150(17)30093.
    PubMed     Text format     Abstract available
    
    
    
89. KITAGAWA K, Amano T, Uetani T, Ishii H, et al
    Association between plaque characteristics and the amount of debris captured by a filter-type distal protection device in patients with acute coronary syndrome.
    Atherosclerosis. 2017;258:72-78.
    PubMed     Text format     Abstract available
    
    
    
90. KWON CH, Kang JG, Lee HJ, Kim NH, et al
    Absence of association between gallstone and coronary artery calcification.
    Atherosclerosis. 2017;258:51-55.
    PubMed     Text format     Abstract available
    
    
    
91. RIZVI A, Hartaigh BO, Danad I, Han D, et al
    Diffuse coronary artery disease among other atherosclerotic plaque characteristics by coronary computed tomography angiography for predicting coronary vessel-specific ischemia by fractional flow reserve.
    Atherosclerosis. 2017;258:145-151.
    PubMed     Text format     Abstract available
    
    
    
92. ABD-ELMONIEM KZ, Ramos N, Yazdani SK, Ghanem AM, et al
    Coronary atherosclerosis and dilation in hyper IgE syndrome patients: Depiction by magnetic resonance vessel wall imaging and pathological correlation.
    Atherosclerosis. 2017;258:20-25.
    PubMed     Text format     Abstract available
    
    
    
93. SHAHID SU, Shabana, Cooper JA, Beaney KE, et al
    Genetic risk analysis of coronary artery disease in Pakistani subjects using a genetic risk score of 21 variants.
    Atherosclerosis. 2017;258:1-7.
    PubMed     Text format     Abstract available
    
    
    
94. CAMPOS AM, Moura FA, Santos SN, Freitas WM, et al
    Sarcopenia, but not excess weight or increased caloric intake, is associated with coronary subclinical atherosclerosis in the very elderly.
    Atherosclerosis. 2017;258:138-144.
    PubMed     Text format     Abstract available
    
    
    
95. MADSEN DM, Diederichsen ACP, Hosbond SE, Gerke O, et al
    Diagnostic and prognostic value of a careful symptom evaluation and high sensitive troponin in patients with suspected stable angina pectoris without prior cardiovascular disease.
    Atherosclerosis. 2017;258:131-137.
    PubMed     Text format     Abstract available
    
    
    February 2017
96. LIU LP, Cheng K, Ning MA, Li HH, et al
    Association between peripheral blood cells mitochondrial DNA content and severity of coronary heart disease.
    Atherosclerosis. 2017 Feb 20. pii: S0021-9150(17)30065.
    PubMed     Text format     Abstract available
    
    
    
97. CHRISTIANSEN MK, Nyegaard M, Pedersen LN, Larsen SB, et al
    A 45-SNP genetic risk score is increased in early-onset coronary artery disease but independent of familial disease clustering.
    Atherosclerosis. 2017;257:172-178.
    PubMed     Text format     Abstract available
    
    
    
98. OSAWA K, Nakanishi R, Budoff MJ
    Is there a role for coronary artery calcification scoring in primary prevention of cerebrovascular disease?
    Atherosclerosis. 2017;257:279-287.
    PubMed     Text format     Abstract available
    
    
    
99. LIN JF, Wu S, Juang JJ, Chiang FT, et al
    IL1RL1 single nucleotide polymorphism predicts sST2 level and mortality in coronary and peripheral artery disease.
    Atherosclerosis. 2017;257:71-77.
    PubMed     Text format     Abstract available
    
    
    
100. DE VRIES MA, Trompet S, Mooijaart SP, Smit RA, et al
     Complement receptor 1 gene polymorphisms are associated with cardiovascular risk.
     Atherosclerosis. 2017;257:16-21.
     PubMed     Text format     Abstract available
     
     
     
101. KIM J, Budoff MJ, Nasir K, Wong ND, et al
     Thoracic aortic calcium, cardiovascular disease events, and all-cause mortality in asymptomatic individuals with zero coronary calcium: The Multi-Ethnic Study of Atherosclerosis (MESA).
     Atherosclerosis. 2017;257:1-8.
     PubMed     Text format     Abstract available
     
     
     
102. LEE EM, Choi MH, Seo HS, Kim HK, et al
     Impact of vasomotion type on prognosis of coronary artery spasm induced by acetylcholine provocation test of left coronary artery.
     Atherosclerosis. 2017;257:195-200.
     PubMed     Text format     Abstract available
     
     
     
103. CHEEZUM MK, Kim A, Bittencourt MS, Kassop D, et al
     Association of tobacco use and cessation with coronary atherosclerosis.
     Atherosclerosis. 2017;257:201-207.
     PubMed     Text format     Abstract available
     
     
     January 2017
104. MAILE LA, Busby WH, Xi G, Gollahan KP, et al
     An anti-alphaVbeta3 antibody inhibits coronary artery atherosclerosis in diabetic pigs.
     Atherosclerosis. 2017;258:40-50.
     PubMed     Text format     Abstract available
     
     
     
105. WIDHALM K, Benke IM, Fritz M, Geiger H, et al
     Homozygous familial hypercholesterolemia: Summarized case reports.
     Atherosclerosis. 2017;257:86-89.
     PubMed     Text format     Abstract available
     
     
     
106. BRUCKERT E, Kalmykova O, Bittar R, Carreau V, et al
     Long-term outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France.
     Atherosclerosis. 2017;257:130-137.
     PubMed     Text format     Abstract available
     
     
     
107. BOS S, Duvekot MH, Ten Kate GR, Verhoeven AJ, et al
     Carotid artery plaques and intima medial thickness in familial hypercholesteraemic patients on long-term statin therapy: A case control study.
     Atherosclerosis. 2017;256:62-66.
     PubMed     Text format     Abstract available
     
     
     
108. NONIN S, Iwata S, Sugioka K, Fujita S, et al
     Plaque surface irregularity and calcification length within carotid plaque predict secondary events in patients with coronary artery disease.
     Atherosclerosis. 2017;256:29-34.
     PubMed     Text format     Abstract available
     
     
     December 2016
109. LEE DH, Chun EJ, Hur JH, Min SH, et al
     Effect of sarpogrelate, a selective 5-HT2A receptor antagonist, on characteristics of coronary artery disease in patients with type 2 diabetes.
     Atherosclerosis. 2016;257:47-54.
     PubMed     Text format     Abstract available
     
     
     
110. RASMUSSEN KL
     Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review.
     Atherosclerosis. 2016;255:145-155.
     PubMed     Text format     Abstract available
     
     
     November 2016
111. SCICALI R, Giral P, Gallo A, Di Pino A, et al
     HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients.
     Atherosclerosis. 2016;255:102-108.
     PubMed     Text format     Abstract available
     
     
     
112. NAKANISHI R, Ceponiene I, Osawa K, Luo Y, et al
     Plaque progression assessed by a novel semi-automated quantitative plaque software on coronary computed tomography angiography between diabetes and non-diabetes patients: A propensity-score matching study.
     Atherosclerosis. 2016;255:73-79.
     PubMed     Text format     Abstract available
     
     
     October 2016
113. LU Y, Cheng Z, Zhao Y, Chang X, et al
     Efficacy and safety of long-term treatment with statins for coronary heart disease: A Bayesian network meta-analysis.
     Atherosclerosis. 2016;254:215-227.
     PubMed     Text format     Abstract available
     
     
     
114. OGURA M, Makino H, Kamiya C, Yoshimatsu J, et al
     Lipoprotein apheresis is essential for managing pregnancies in patients with homozygous familial hypercholesterolemia: Seven case series and discussion.
     Atherosclerosis. 2016;254:179-183.
     PubMed     Text format     Abstract available
     
     
     September 2016
115. GUO XY, Li N, Du X, Bai R, et al
     Atrial fibrillation is associated with an increased risk of myocardial infarction: Insights from a meta-analysis.
     Atherosclerosis. 2016;254:1-7.
     PubMed     Text format     Abstract available
     
     
     
116. ELAJAMI TK, Giuseffi J, Avila MD, Hovnanians N, et al
     Parity, coronary heart disease and mortality in the old order Amish.
     Atherosclerosis. 2016;254:14-19.
     PubMed     Text format     Abstract available
     
     
     
117. MANGILI LC, Mangili OC, Bittencourt MS, Miname MH, et al
     Epicardial fat is associated with severity of subclinical coronary atherosclerosis in familial hypercholesterolemia.
     Atherosclerosis. 2016;254:73-77.
     PubMed     Text format     Abstract available
     
     
     
118. SANTOS-GALLEGO CG, Wallert M, Peter K
     Myocardial infarction caused by surgery: Blame inflammation not the surgeon.
     Atherosclerosis. 2016 Sep 1. pii: S0021-9150(16)31312.
     PubMed     Text format    
     
     
     August 2016
119. ALONSO R, Mata P, Muniz O, Fuentes-Jimenez F, et al
     PCSK9 and lipoprotein (a) levels are two predictors of coronary artery calcification in asymptomatic patients with familial hypercholesterolemia.
     Atherosclerosis. 2016 Aug 27. pii: S0021-9150(16)31306.
     PubMed     Text format     Abstract available
     
     
     
120. ZENG L, Dang TA, Schunkert H
     Genetics links between transforming growth factor beta pathway and coronary disease.
     Atherosclerosis. 2016 Aug 25. pii: S0021-9150(16)31290.
     PubMed     Text format     Abstract available
     
     
     
121. IKEDA N, Hara H, Hiroi Y, Nakamura M, et al
     Impact of serum 1,5-anhydro-d-glucitol level on prediction of major adverse cardiac and cerebrovascular events in non-diabetic patients without coronary artery disease.
     Atherosclerosis. 2016;253:1-6.
     PubMed     Text format     Abstract available
     
     
     July 2016
122. WATTS GF, Pang J, Chan DC, Brunt JN, et al
     Angiographic progression of coronary atherosclerosis in patients with familial hypercholesterolaemia treated with non-statin therapy: Impact of a fat-modified diet and a resin.
     Atherosclerosis. 2016;252:82-87.
     PubMed     Text format     Abstract available
     
     
     
123. VISSERS LE, Waller MA, van der Schouw YT, Hebert JR, et al
     The relationship between the dietary inflammatory index and risk of total cardiovascular disease, ischemic heart disease and cerebrovascular disease: Findings from an Australian population-based prospective cohort study of women.
     Atherosclerosis. 2016 Jul 30. pii: S0021-9150(16)31230.
     PubMed     Text format     Abstract available
     
     
     
124. YUBERO-SERRANO EM, Delgado-Lista J, Alcala-Diaz JF, Garcia-Rios A, et al
     A dysregulation of glucose metabolism control is associated with carotid atherosclerosis in patients with coronary heart disease (CORDIOPREV-DIAB study).
     Atherosclerosis. 2016 Jul 16. pii: S0021-9150(16)31204.
     PubMed     Text format     Abstract available
     
     
     June 2016
125. DISTELMAIER K, Schrutka L, Wurm R, Seidl V, et al
     Gender-related impact on outcomes of high density lipoprotein in acute ST-elevation myocardial infarction.
     Atherosclerosis. 2016 Jun 24. pii: S0021-9150(16)30282.
     PubMed     Text format     Abstract available
     
     
     
126. LOUWE MC, Lammers B, Frias MA, Foks AC, et al
     Abca1 deficiency protects the heart against myocardial infarction-induced injury.
     Atherosclerosis. 2016;251:159-163.
     PubMed     Text format     Abstract available
     
     
     
127. MENZEL J, di Giuseppe R, Biemann R, Wittenbecher C, et al
     Omentin-1 and risk of myocardial infarction and stroke: Results from the EPIC-Potsdam cohort study.
     Atherosclerosis. 2016 Jun 2. pii: S0021-9150(16)30243.
     PubMed     Text format     Abstract available
     
     
     May 2016
128. NARDIN M, Verdoia M, Schaffer A, Barbieri L, et al
     Vitamin D status, diabetes mellitus and coronary artery disease in patients undergoing coronary angiography.
     Atherosclerosis. 2016;250:114-121.
     PubMed     Text format     Abstract available
     
     
     
129. MENEGAUT L, Masson D, Abello N, Denimal D, et al
     Specific enrichment of 2-arachidonoyl-lysophosphatidylcholine in carotid atheroma plaque from type 2 diabetic patients.
     Atherosclerosis. 2016 May 4. pii: S0021-9150(16)30164.
     PubMed     Text format     Abstract available
     
     
     
130. MANTAS D, Markopoulos C
     Screening mammography: Usefulness beyond early detection of breast cancer.
     Atherosclerosis. 2016;248:1.
     PubMed     Text format    
     
     
     
131. PARK SJ, Yang HM, Seo KW, Choi SY, et al
     The relationship between coronary atherosclerosis and body fat distribution measured using dual energy X-ray absorptiometry.
     Atherosclerosis. 2016;248:190-5.
     PubMed     Text format     Abstract available
     
     
     
132. YONGSAKULCHAI P, Settasatian C, Settasatian N, Komanasin N, et al
     Association of combined genetic variations in PPARgamma, PGC-1alpha, and LXRalpha with coronary artery disease and severity in Thai population.
     Atherosclerosis. 2016;248:140-8.
     PubMed     Text format     Abstract available
     
     
     
133. CHENG JM, Oemrawsingh RM, Garcia-Garcia HM, Boersma E, et al
     PCSK9 in relation to coronary plaque inflammation: Results of the ATHEROREMO-IVUS study.
     Atherosclerosis. 2016;248:117-22.
     PubMed     Text format     Abstract available
     
     
     
134. GLEISSNER CA
     Translational atherosclerosis research: From experimental models to coronary artery disease in humans.
     Atherosclerosis. 2016;248:110-6.
     PubMed     Text format     Abstract available
     
     
     
135. CAHILL PA, Redmond EM
     Vascular endothelium - Gatekeeper of vessel health.
     Atherosclerosis. 2016;248:97-109.
     PubMed     Text format     Abstract available
     
     
     April 2016
136. MIRANDA CH, de Carvalho Borges M, Schmidt A, Marin-Neto JA, et al
     Evaluation of the endothelial glycocalyx damage in patients with acute coronary syndrome.
     Atherosclerosis. 2016;247:184-8.
     PubMed     Text format     Abstract available
     
     
     
137. OEMRAWSINGH RM, Cheng JM, Garcia-Garcia HM, Kardys I, et al
     High-sensitivity Troponin T in relation to coronary plaque characteristics in patients with stable coronary artery disease; results of the ATHEROREMO-IVUS study.
     Atherosclerosis. 2016;247:135-41.
     PubMed     Text format     Abstract available
     
     
     
138. DAI J, Tian J, Hou J, Xing L, et al
     Association between cholesterol crystals and culprit lesion vulnerability in patients with acute coronary syndrome: An optical coherence tomography study.
     Atherosclerosis. 2016;247:111-7.
     PubMed     Text format     Abstract available
     
     
     
139. NAITO R, Miyauchi K, Konishi H, Tsuboi S, et al
     Gender difference in long-term clinical outcomes following percutaneous coronary intervention during 1984-2008.
     Atherosclerosis. 2016;247:105-10.
     PubMed     Text format     Abstract available
     
     
     
140. SKAGEN K, Troseid M, Ueland T, Holm S, et al
     The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis.
     Atherosclerosis. 2016;247:64-9.
     PubMed     Text format     Abstract available
     
     
     
141. CAVALCANTE R, Bittencourt MS, Pinheiro TL, Falcao BA, et al
     Validation of coronary computed tomography angiography scores for non-invasive assessment of atherosclerotic burden through a comparison with multivessel intravascular ultrasound.
     Atherosclerosis. 2016;247:21-7.
     PubMed     Text format     Abstract available
     
     
     February 2016
142. MULDERS TA, Taraboanta C, Franken LC, van Heel E, et al
     Coronary artery calcification score as tool for risk assessment among families with premature coronary artery disease.
     Atherosclerosis. 2016;245:155-60.
     PubMed     Text format     Abstract available
     
     
     
143. GUO L, Wang L, Li H, Yang X, et al
     Down regulation of GALNT3 contributes to endothelial cell injury via activation of p38 MAPK signaling pathway.
     Atherosclerosis. 2016;245:94-100.
     PubMed     Text format     Abstract available
     
     
     
144. OLSON F, Engborg J, Gronhoj MH, Sand NP, et al
     Association between high-sensitive troponin I and coronary artery calcification in a Danish general population.
     Atherosclerosis. 2016;245:88-93.
     PubMed     Text format     Abstract available
     
     
     
145. SUH B, Park S, Shin DW, Ahn H, et al
     Early repolarization is associated with significant coronary artery stenosis in asymptomatic adults.
     Atherosclerosis. 2016;245:50-3.
     PubMed     Text format     Abstract available
     
     
     
146. VAGNARELLI F, Corsini A, Lorenzini M, Ortolani P, et al
     Long-term prognostic role of cerebrovascular disease and peripheral arterial disease across the spectrum of acute coronary syndromes.
     Atherosclerosis. 2016;245:43-9.
     PubMed     Text format     Abstract available
     
     
     
147. CRAIEM D, Chironi DG, Casciaro ME, Sirieix ME, et al
     Association of thoracic aorta calcium and non cardiac vascular events in cardiac disease-free individuals.
     Atherosclerosis. 2016;245:22-7.
     PubMed     Text format     Abstract available
     
     
     January 2016
148. OGITA M, Miyauchi K, Kasai T, Tsuboi S, et al
     Prognostic impact of circulating soluble LR11 on long-term clinical outcomes in patients with coronary artery disease.
     Atherosclerosis. 2016;244:216-21.
     PubMed     Text format     Abstract available
     
     
     
149. SAELY CH, Leiherer A, Muendlein A, Vonbank A, et al
     High plasma omentin predicts cardiovascular events independently from the presence and extent of angiographically determined atherosclerosis.
     Atherosclerosis. 2016;244:38-43.
     PubMed     Text format     Abstract available
     
     
     December 2015
150. RHEE EJ, Kim JH, Park HJ, Park SE, et al
     Increased risk for development of coronary artery calcification in insulin-resistant subjects who developed diabetes: 4-year longitudinal study.
     Atherosclerosis. 2015;245:132-138.
     PubMed     Text format     Abstract available
     
     
     November 2015
151. CHEN X, Bakillah A, Zhou L, Pan X, et al
     Nitrated apolipoprotein AI/apolipoprotein AI ratio is increased in diabetic patients with coronary artery disease.
     Atherosclerosis. 2015;245:12-21.
     PubMed     Text format     Abstract available
     
     
     October 2015
152. PURI R, Nissen SE, Menon V, Shao M, et al
     Effects of aliskiren in diabetic and non-diabetic patients with coronary artery disease: Insights from AQUARIUS.
     Atherosclerosis. 2015;243:553-559.
     PubMed     Text format     Abstract available
     
     
     September 2015
153. MOURA FA, Figueiredo VN, Teles BS, Barbosa MA, et al
     Glycosylated hemoglobin is associated with decreased endothelial function, high inflammatory response, and adverse clinical outcome in non-diabetic STEMI patients.
     Atherosclerosis. 2015;243:124-130.
     PubMed     Text format     Abstract available
     
     
     
154. SHIN DG, Han SM, Kim DI, Rhee MY, et al
     Clinical features of familial hypercholesterolemia in Korea: Predictors of pathogenic mutations and coronary artery disease - A study supported by the Korean Society of Lipidology and Atherosclerosis.
     Atherosclerosis. 2015;243:53-58.
     PubMed     Text format     Abstract available
     
     
     
155. TZIOMALOS K, Giampatzis V, Bouziana SD, Spanou M, et al
     Comparative effects of more versus less aggressive treatment with statins on the long-term outcome of patients with acute ischemic stroke.
     Atherosclerosis. 2015;243:65-70.
     PubMed     Text format     Abstract available
     
     
     
156. BARKAS F, Elisaf M, Milionis H
     Statins decrease the risk of stroke in individuals with heterozygous familial hypercholesterolemia: A systematic review and meta-analysis.
     Atherosclerosis. 2015;243:60-64.
     PubMed     Text format     Abstract available
     
     
     August 2015
157. YU HH, Chen PC, Yang YH, Wang LC, et al
     Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: A nationwide population-based cohort study.
     Atherosclerosis. 2015;243:11-18.
     PubMed     Text format     Abstract available
     
     
     July 2015
158. PRUDENTE S, Bailetti D, Mendonca C, Mannino GC, et al
     Infrequent TRIB3 coding variants and coronary artery disease in type 2 diabetes.
     Atherosclerosis. 2015;242:334-339.
     PubMed     Text format     Abstract available
     
     
     
159. TANAKA A, Ishii H, Oshima H, Narita Y, et al
     Inverse association between diabetes and aortic dilatation in patients with advanced coronary artery disease.
     Atherosclerosis. 2015;242:123-127.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: